Data for: The JNK inhibitor AS602801 Synergizes with Enzalutamide to kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression

Published: 18 March 2020| Version 1 | DOI: 10.17632/zpyh5ybtkj.1
Carlos Moreno,
Adeboye Osunkoya,
Carrie Sun,
Zhenghong Li,
xiongbing zu,
Sijia Tao,
John Petros,
Rebecca Arnold


Nanostring data from pancancer panel analysis of LNCaP cells treated with AS602801, Enzalutamide, or both.